A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Amlexanox
Nilotinib
The metabolism of Phenacetin can be decreased when combined with Nilotinib.
Amlexanox
Manidipine
The metabolism of Phenacetin can be decreased when combined with Manidipine.
Amlexanox
Sulfaphenazole
The metabolism of Phenacetin can be decreased when combined with Sulfaphenazole.
Amlexanox
Osilodrostat
The metabolism of Phenacetin can be decreased when combined with Osilodrostat.
Amlexanox
Pazufloxacin
The metabolism of Phenacetin can be decreased when combined with Pazufloxacin.
Amlexanox
Lobeglitazone
The metabolism of Phenacetin can be decreased when combined with Lobeglitazone.
Amlexanox
Simeprevir
The metabolism of Phenacetin can be decreased when combined with Simeprevir.
Amlexanox
Gatifloxacin
The metabolism of Phenacetin can be decreased when combined with Gatifloxacin.
Amlexanox
Cyproterone acetate
The metabolism of Phenacetin can be increased when combined with Cyproterone acetate.
Amlexanox
Abiraterone
The serum concentration of Phenacetin can be increased when it is combined with Abiraterone.
Amlexanox
Teriflunomide
The serum concentration of Phenacetin can be decreased when it is combined with Teriflunomide.
Amlexanox
Deferasirox
The serum concentration of Phenacetin can be increased when it is combined with Deferasirox.
Phylloquinone
Belantamab mafodotin
Deoxycholic acid may increase the excretion rate of Belantamab mafodotin which could result in a lower serum level and potentially a reduction in efficacy.
Phylloquinone
Glycyrrhizic acid
Deoxycholic acid may increase the excretion rate of Glycyrrhizic acid which could result in a lower serum level and potentially a reduction in efficacy.
Phylloquinone
Dihydroergocristine
Deoxycholic acid may increase the excretion rate of Dihydroergocristine which could result in a lower serum level and potentially a reduction in efficacy.
Phylloquinone
Pilsicainide
Deoxycholic acid may increase the excretion rate of Pilsicainide which could result in a lower serum level and potentially a reduction in efficacy.
Phylloquinone
Benzbromarone
Deoxycholic acid may increase the excretion rate of Benzbromarone which could result in a lower serum level and potentially a reduction in efficacy.
Phylloquinone
Indocyanine green acid form
Deoxycholic acid may increase the excretion rate of Indocyanine green acid form which could result in a lower serum level and potentially a reduction in efficacy.
Phylloquinone
Pitavastatin
Deoxycholic acid may increase the excretion rate of Pitavastatin which could result in a lower serum level and potentially a reduction in efficacy.
Phylloquinone
Prasterone sulfate
Deoxycholic acid may increase the excretion rate of Prasterone sulfate which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3